Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH).
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000526:Alprenolol / Q000494:pharmacology; D001775:Blood Circulation / Q000187:drug effects; D005260:Female; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D010096:Oxprenolol / Q000494:pharmacology / Q000627:therapeutic use; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D013610:Tachycardia / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol